Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and furosemide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with furosemide in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(furosemide)
Trials
(furosemide)
Recent Studies (post-2010) (furosemide)
9,15618755213,6311,3582,486

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)furosemide (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)3.76
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)3.76
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)3.2

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jewell, DP; Travis, SP1
Buckley, TL; Hoult, JR1
Achaval, M; Barberà, JA; Chung, KF; Echazarreta, AL; Gómez, FP; Ribas, J; Roca, J; Rodriguez-Roisin, R1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and furosemide

ArticleYear
Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma.
    The European respiratory journal, 1999, Volume: 14, Issue:3

    Topics: Administration, Inhalation; Adult; Airway Resistance; Asthma; Blood Gas Analysis; Bronchoconstriction; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Furosemide; Humans; Leukocyte Count; Leukotriene E4; Male; Nebulizers and Vaporizers; Platelet Activating Factor; Pulmonary Gas Exchange

1999

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and furosemide

ArticleYear
Regional differences in the response to platelet-activating factor in rabbit colon.
    Clinical science (London, England : 1979), 1992, Volume: 82, Issue:6

    Topics: Animals; Cecum; Cell Membrane Permeability; Chlorides; Colon; Dose-Response Relationship, Drug; Electric Conductivity; Furosemide; In Vitro Techniques; Mannitol; Platelet Activating Factor; Rabbits; Sodium; Time Factors

1992
Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors.
    European journal of pharmacology, 1989, Apr-25, Volume: 163, Issue:2-3

    Topics: Animals; Bradykinin; Calcium; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Electrophysiology; Furosemide; Intestinal Mucosa; Male; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors

1989